Sign Out
Susceptible microorganisms: E. coli, Shigella, Salmonella, Citrobacter, Klebsiella, Enterobacter, Serratia, Proteus (indole positive and negative), Pseudomonas, Neisseria, Acinetobacter, Streptococcus, Chlamydia, Staphylococcus, Corynebacterium, Bacteroides, Clostridium.
Infectious diseases: Respiratory Tract Infections; Ear, nose, throat infections; Kidney or urinary tract infections; Genital tract infections including gonorrhea; Infections of the gastrointestinal tract; Biliary tract infections; Infections of the skin and soft tissue; Infections of the bones and joints; Gynecological infections; Sepsis and peritonitis.
Because fluoroquinolones, including ciprofloxacin, have been associated with serious adverse reactions, reserve ciprofloxacin for treatment of acute exacerbation of chronic bronchitis, and simple urinary tract infections in patients who have no alternative treatment options.
